Literature DB >> 25740504

Nicotinic receptor subtype-selective circuit patterns in the subthalamic nucleus.

Cheng Xiao1, Julie M Miwa2, Brandon J Henderson1, Ying Wang1, Purnima Deshpande1, Sheri L McKinney1, Henry A Lester3.   

Abstract

The glutamatergic subthalamic nucleus (STN) exerts control over motor output through nuclei of the basal ganglia. High-frequency electrical stimuli in the STN effectively alleviate motor symptoms in movement disorders, and cholinergic stimulation boosts this effect. To gain knowledge about the mechanisms of cholinergic modulation in the STN, we studied cellular and circuit aspects of nicotinic acetylcholine receptors (nAChRs) in mouse STN. We discovered two largely divergent microcircuits in the STN; these are regulated in part by either α4β2 or α7 nAChRs. STN neurons containing α4β2 nAChRs (α4β2 neurons) received more glutamatergic inputs, and preferentially innervated GABAergic neurons in the substantia nigra pars reticulata. In contrast, STN neurons containing α7 nAChRs (α7 neurons) received more GABAergic inputs, and preferentially innervated dopaminergic neurons in the substantia nigra pars compacta. Interestingly, local electrical stimuli excited a majority (79%) of α4β2 neurons but exerted strong inhibition in 58% of α7 neurons, indicating an additional diversity of STN neurons: responses to electrical stimulation. Chronic exposure to nicotine selectively affects α4β2 nAChRs in STN: this treatment increased the number of α4β2 neurons, upregulated α4-containing nAChR number and sensitivity, and enhanced the basal firing rate of α4β2 neurons both ex vivo and in vivo. Thus, chronic nicotine enhances the function of the microcircuit involving α4β2 nAChRs. This indicates chronic exposure to nicotinic agonist as a potential pharmacological intervention to alter selectively the balance between these two microcircuits, and may provide a means to inhibit substantia nigra dopaminergic neurons.
Copyright © 2015 the authors 0270-6474/15/353734-13$15.00/0.

Entities:  

Keywords:  Parkinson's disease; alpha4beta2; alpha7; chronic nicotine; substantia nigra; upregulation

Mesh:

Substances:

Year:  2015        PMID: 25740504      PMCID: PMC4348180          DOI: 10.1523/JNEUROSCI.3528-14.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  78 in total

1.  "Orphan" alpha6 nicotinic AChR subunit can form a functional heteromeric acetylcholine receptor.

Authors:  V Gerzanich; A Kuryatov; R Anand; J Lindstrom
Journal:  Mol Pharmacol       Date:  1997-02       Impact factor: 4.436

2.  Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity.

Authors:  Y Smith; A Parent
Journal:  Brain Res       Date:  1988-06-21       Impact factor: 3.252

3.  Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment.

Authors:  M J Marks; J R Pauly; S D Gross; E S Deneris; I Hermans-Borgmeyer; S F Heinemann; A C Collins
Journal:  J Neurosci       Date:  1992-07       Impact factor: 6.167

4.  Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes.

Authors:  L E Chavez-Noriega; J H Crona; M S Washburn; A Urrutia; K J Elliott; E C Johnson
Journal:  J Pharmacol Exp Ther       Date:  1997-01       Impact factor: 4.030

5.  The kinetics of tubocurarine action and restricted diffusion within the synaptic cleft.

Authors:  D L Armstrong; H A Lester
Journal:  J Physiol       Date:  1979-09       Impact factor: 5.182

6.  Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion.

Authors:  A C Collins; Y Luo; S Selvaag; M J Marks
Journal:  J Pharmacol Exp Ther       Date:  1994-10       Impact factor: 4.030

7.  Autoradiographic localization of putative nicotinic receptors in the rat brain using 125I-neuronal bungarotoxin.

Authors:  D W Schulz; R H Loring; E Aizenman; R E Zigmond
Journal:  J Neurosci       Date:  1991-01       Impact factor: 6.167

8.  Distribution of nicotinic receptors in cynomolgus monkey brain and ganglia: localization of alpha 3 subunit mRNA, alpha-bungarotoxin and nicotine binding sites.

Authors:  M Cimino; P Marini; D Fornasari; F Cattabeni; F Clementi
Journal:  Neuroscience       Date:  1992-11       Impact factor: 3.590

9.  GABAA receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons.

Authors:  J M Tepper; L P Martin; D R Anderson
Journal:  J Neurosci       Date:  1995-04       Impact factor: 6.167

10.  The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism.

Authors:  T Wichmann; H Bergman; M R DeLong
Journal:  J Neurophysiol       Date:  1994-08       Impact factor: 2.714

View more
  14 in total

Review 1.  The external globus pallidus: progress and perspectives.

Authors:  Daniel J Hegeman; Ellie S Hong; Vivian M Hernández; C Savio Chan
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

2.  Why flavored vape products may be attractive: Green apple tobacco flavor elicits reward-related behavior, upregulates nAChRs on VTA dopamine neurons, and alters midbrain dopamine and GABA neuron function.

Authors:  Alicia J Avelar; Austin T Akers; Zachary J Baumgard; Skylar Y Cooper; Gabriella P Casinelli; Brandon J Henderson
Journal:  Neuropharmacology       Date:  2019-07-29       Impact factor: 5.250

3.  Cholinergic Mesopontine Signals Govern Locomotion and Reward through Dissociable Midbrain Pathways.

Authors:  Cheng Xiao; Jounhong Ryan Cho; Chunyi Zhou; Jennifer B Treweek; Ken Chan; Sheri L McKinney; Bin Yang; Viviana Gradinaru
Journal:  Neuron       Date:  2016-04-20       Impact factor: 17.173

4.  Internal States Influence the Representation and Modulation of Food Intake by Subthalamic Neurons.

Authors:  Haichuan Wu; Xiang Yan; Dongliang Tang; Weixin Gu; Yiwen Luan; Haijiang Cai; Chunyi Zhou; Cheng Xiao
Journal:  Neurosci Bull       Date:  2020-06-21       Impact factor: 5.203

Review 5.  The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function.

Authors:  Melissa L Sinkus; Sharon Graw; Robert Freedman; Randal G Ross; Henry A Lester; Sherry Leonard
Journal:  Neuropharmacology       Date:  2015-02-19       Impact factor: 5.250

6.  Differential Control of Dopaminergic Excitability and Locomotion by Cholinergic Inputs in Mouse Substantia Nigra.

Authors:  Jasem Estakhr; Danya Abazari; Kaitlyn Frisby; J Michael McIntosh; Raad Nashmi
Journal:  Curr Biol       Date:  2017-06-22       Impact factor: 10.834

Review 7.  The Subthalamic Nucleus: Unravelling New Roles and Mechanisms in the Control of Action.

Authors:  Tora Bonnevie; Kareem A Zaghloul
Journal:  Neuroscientist       Date:  2018-03-20       Impact factor: 7.519

8.  Parvalbumin+ and Npas1+ Pallidal Neurons Have Distinct Circuit Topology and Function.

Authors:  Arin Pamukcu; Qiaoling Cui; Harry S Xenias; Brianna L Berceau; Elizabeth C Augustine; Isabel Fan; Saivasudha Chalasani; Adam W Hantman; Talia N Lerner; Simina M Boca; C Savio Chan
Journal:  J Neurosci       Date:  2020-08-31       Impact factor: 6.167

9.  Npas1+ Pallidal Neurons Target Striatal Projection Neurons.

Authors:  Kelly E Glajch; Daniel A Kelver; Daniel J Hegeman; Qiaoling Cui; Harry S Xenias; Elizabeth C Augustine; Vivian M Hernández; Neha Verma; Tina Y Huang; Minmin Luo; Nicholas J Justice; C Savio Chan
Journal:  J Neurosci       Date:  2016-05-18       Impact factor: 6.167

10.  Optogenetic stimulation of cortico-subthalamic projections is sufficient to ameliorate bradykinesia in 6-ohda lesioned mice.

Authors:  Teresa H Sanders; Dieter Jaeger
Journal:  Neurobiol Dis       Date:  2016-07-21       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.